Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2 inhibitor from Searle

April 15, 1997

Immunex's Enbrel demonstrates positive safety profile in RA patients

April 14, 1997

Wyeth-Ayerst and Elan develop new formulation of Lodine

April 11, 1997

NitroMed/J&J divisions collaborate on NSAID/NO donor compounds

April 9, 1997

Pivotal trial of Therafectin enrolled

April 3, 1997

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Protein Design Labs grants license to IDEC for humanized MAb

March 25, 1997

Antiinflammatory protein described by New York University

March 25, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

Nippon Shinyaku discloses cell adhesion inhibitors

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...